Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 134241,
    "name": "Jagsonpal Pharma",
    "stock_name": "Jagsonpal Pharma",
    "full_name": "Jagsonpal Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/jagsonpal-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "210.85",
    "chg": 1.25,
    "chgp": "0.6%",
    "dir": 1,
    "prev_price": "209.60",
    "mcapval": "1,388.14 Cr",
    "mcap": "Small Cap",
    "scripcode": 507789,
    "symbol": "JAGSNPHARM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE048B01035",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "44.25 k",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/jagsonpal-pharma-134241-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Jagsonpal Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jagsonpal-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-signals-3986229",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/JagsonpalPharma_technicaldot_3986229.png",
        "date": "2026-05-12 08:00:26",
        "description": "Jagsonpal Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite some bullish weekly indicators, monthly signals suggest caution, reflecting a complex technical landscape for this micro-cap player in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Gains 2.66%: 3 Key Factors Driving the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jagsonpal-pharmaceuticals-gains-266-3-key-factors-driving-the-week-3984314",
        "imagepath": "",
        "date": "2026-05-10 16:01:02",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>4 May:</strong> Week opens at Rs.212.25</p>\n                    <p><strong>5 May:</strong> Technical momentum shifts amid mixed indicator signals</p>\n                    <p><strong>7 May:</strong> Mojo Grade upgraded from Strong Sell to Sell</p>\n                    <p><strong>8 May:</strong> Stock closes at Rs.217.90, up 2.13% on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.212.25</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.217.90</div><div class=\"stat-change positiv..."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jagsonpal-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3980590",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/JagsonpalPharma_technicaldot_3980590.png",
        "date": "2026-05-08 08:00:16",
        "description": "Jagsonpal Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a modest day gain of 1.84%, the stock’s technical indicators present a complex picture, with mixed signals across weekly and monthly timeframes, reflecting uncertainty in near-term price direction."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jagsonpal-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3974561",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/JagsonpalPharma_technicaldot_3974561.png",
        "date": "2026-05-05 08:00:16",
        "description": "Jagsonpal Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a modest day gain of 0.93%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, Bollinger Bands, and moving averages, reflecting cautious investor sentiment in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Ltd: Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jagsonpal-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3967335",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/JagsonpalPharma_technicaldot_3967335.png",
        "date": "2026-04-29 08:00:12",
        "description": "Jagsonpal Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, is currently exhibiting a complex technical profile with a shift from mildly bearish to sideways momentum. Despite a modest day gain of 1.20%, the stock’s technical indicators present a nuanced picture, reflecting both bullish and bearish signals across weekly and monthly timeframes."
      },
      {
        "title": "Are Jagsonpal Pharmaceuticals Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-jagsonpal-pharmaceuticals-ltd-latest-results-good-or-bad-3967118",
        "imagepath": "",
        "date": "2026-04-28 19:13:41",
        "description": "Jagsonpal Pharmaceuticals Ltd's latest financial results for Q4 FY26 present a mixed picture. The company reported a net profit of ₹8.76 crores, reflecting a year-on-year growth of 33.13%. However, this represents a sequential decline of 20.00% compared to the previous quarter. Similarly, revenue for the quarter was ₹64.20 crores, which is a 9.63% increase year-on-year but shows a significant sequential contraction of 11.99% from ₹72.95 crores in Q3 FY26. \n\nThe operating margin, excluding other income, was recorded at 17.38%, which is an improvement of 248 basis points year-on-year but a notable decrease of 494 basis points from the previous quarter's margin of 22.32%. This decline in margins raises concerns about the company's operational efficiency and cost management in the face of revenue pressures.\n\nOverall, while Jagsonpal Pharmaceuticals has demonstrated resilience in year-on-year comparisons, the se..."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jagsonpal-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicators-3965311",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/JagsonpalPharma_technicaldot_3965311.png",
        "date": "2026-04-28 08:00:21",
        "description": "Jagsonpal Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, with recent indicators signalling a transition from sideways to mildly bearish trends. Despite a 2.26% gain on 28 Apr 2026, the stock’s technical parameters present a complex picture, reflecting both bullish and bearish signals across different timeframes."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jagsonpal-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-market-signals-3947995",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/JagsonpalPharma_technicaldot_3947995.png",
        "date": "2026-04-16 08:00:19",
        "description": "Jagsonpal Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish indicators. Despite a marginal day decline of 0.05%, the stock’s technical parameters reveal a sideways trend, signalling a pause after recent volatility and prompting a reassessment of its near-term outlook."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jagsonpal-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicators-3946363",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/JagsonpalPharma_technicaldot_3946363.png",
        "date": "2026-04-15 08:00:08",
        "description": "Jagsonpal Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a modest 1.14% gain on 15 Apr 2026, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, Bollinger Bands, and moving averages suggesting cautious investor sentiment in the Pharmaceuticals & Biotechnology sector."
      }
    ],
    "total": 15,
    "sid": "134241",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/jagsonpal-pharmaceuticals-134241"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
      "datetime": "04-Jun-2026",
      "details": "Allotment of 296320 Equity Shares under the Jagsonpal Pharmaceuticals Limited Employee Stock Option Plan 2022.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Closure of Buy Back",
      "datetime": "02-Jun-2026",
      "details": "Extinguishment of 1600000 Equity Shares of Jagsonpal Pharmaceuticals Limited.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "28-May-2026",
      "details": "Please find enclosed Annual Secretarial Compliance Report for the Financial Year ended March 31 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Jagsonpal Pharmaceuticals Ltd has declared <strong>125%</strong> dividend, ex-date: 12 Sep 25",
          "dt": "2025-09-12",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Jagsonpal Pharmaceuticals Ltd has announced <strong>2:5</strong> stock split, ex-date: 08 Jan 25",
          "dt": "2025-01-08",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Jagsonpal Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Signals

2026-05-12 08:00:26

Jagsonpal Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite some bullish weekly indicators, monthly signals suggest caution, reflecting a complex technical landscape for this micro-cap player in the Pharmaceuticals & Biotechnology sector.

Jagsonpal Pharmaceuticals Gains 2.66%: 3 Key Factors Driving the Week

2026-05-10 16:01:02

Key Events This Week 4 May: Week opens at Rs.212.25 5 May: Technical momentum shifts amid mixed indicator signals 7 May: Mojo Grade upgraded from Strong Sell to Sell 8 May: Stock closes at Rs.217.90, up 2.13% on the day Week OpenRs.212.25 Week CloseRs.217.90<div class="stat-change positiv...

Jagsonpal Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-05-08 08:00:16

Jagsonpal Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a modest day gain of 1.84%, the stock’s technical indicators present a complex picture, with mixed signals across weekly and monthly timeframes, reflecting uncertainty in near-term price direction.

Jagsonpal Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-05-05 08:00:16

Jagsonpal Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a modest day gain of 0.93%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, Bollinger Bands, and moving averages, reflecting cautious investor sentiment in the Pharmaceuticals & Biotechnology sector.

Jagsonpal Pharmaceuticals Ltd: Technical Momentum Shifts Amid Mixed Indicator Signals

2026-04-29 08:00:12

Jagsonpal Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, is currently exhibiting a complex technical profile with a shift from mildly bearish to sideways momentum. Despite a modest day gain of 1.20%, the stock’s technical indicators present a nuanced picture, reflecting both bullish and bearish signals across weekly and monthly timeframes.

Are Jagsonpal Pharmaceuticals Ltd latest results good or bad?

2026-04-28 19:13:41

Jagsonpal Pharmaceuticals Ltd's latest financial results for Q4 FY26 present a mixed picture. The company reported a net profit of ₹8.76 crores, reflecting a year-on-year growth of 33.13%. However, this represents a sequential decline of 20.00% compared to the previous quarter. Similarly, revenue for the quarter was ₹64.20 crores, which is a 9.63% increase year-on-year but shows a significant sequential contraction of 11.99% from ₹72.95 crores in Q3 FY26. The operating margin, excluding other income, was recorded at 17.38%, which is an improvement of 248 basis points year-on-year but a notable decrease of 494 basis points from the previous quarter's margin of 22.32%. This decline in margins raises concerns about the company's operational efficiency and cost management in the face of revenue pressures. Overall, while Jagsonpal Pharmaceuticals has demonstrated resilience in year-on-year comparisons, the se...

Jagsonpal Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicators

2026-04-28 08:00:21

Jagsonpal Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, with recent indicators signalling a transition from sideways to mildly bearish trends. Despite a 2.26% gain on 28 Apr 2026, the stock’s technical parameters present a complex picture, reflecting both bullish and bearish signals across different timeframes.

Jagsonpal Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-04-16 08:00:19

Jagsonpal Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish indicators. Despite a marginal day decline of 0.05%, the stock’s technical parameters reveal a sideways trend, signalling a pause after recent volatility and prompting a reassessment of its near-term outlook.

Jagsonpal Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicators

2026-04-15 08:00:08

Jagsonpal Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a modest 1.14% gain on 15 Apr 2026, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, Bollinger Bands, and moving averages suggesting cautious investor sentiment in the Pharmaceuticals & Biotechnology sector.

View All News